EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Enhanced Melan‐A Red Chromogen Labeling in Melanoma Compared to Nevus Cells: A Diagnostic Aid in Dual Multiplex Immunohistochemistry With Ki67

Peter N Kundert iD, Elsayed H Ibrahim iD, Victor G Prieto iD, Phyu P Aung iD

Journal of Cutaneous Pathology · 2026-12 · 53 (12) · 1180-1185

DOI: 10.1111/cup.70170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cutaneous Pathology, online erschienen am 30.07.2026. Verfasst von Peter N Kundert und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Ki-67 Antigen, MART-1 Antigen, Melanoma, Skin Neoplasms. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Distinguishing melanoma cells from nevus cells remains a diagnostic challenge, particularly in cases where melanoma exhibits nevoid morphology or nevus cells display atypical or epithelioid features. Accurate identification is essential for proper measurement of Breslow depth in melanomas arising in association with nevi and for margin assessment, both of which are critical for patient prognosis. The dual multiplex immunohistochemical stain utilizing Melan‐A (red chromogen) and Ki67 (brown chromogen) is a valuable tool for assessing the proliferative index of melanocytic populations, with melanoma cells typically showing a higher Ki67 index than nevus cells.

Methods

We identified 10 cases with invasive melanoma and associated nevus present on the same scanned histologic section for which the signing pathologist had ordered this dual multiplex immunohistochemical study. We annotated areas of melanoma versus nevus, then quantified the staining intensities.

Results

Melanoma cells often demonstrate more intense Melan‐A red chromogen labeling than adjacent nevus cells ( p = 0.008; Wilcoxon signed rank test).

Conclusion

This differential labeling provides a helpful visual distinction between melanoma and nevus cells within the same histologic section, enhancing diagnostic confidence beyond the difference in Ki67 proliferation index.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ki-67 AntigenMART-1 AntigenMelanomaSkin NeoplasmsNevusHumansImmunohistochemistryFemaleDiagnosis, DifferentialMaleBiomarkers, TumorMiddle AgedAdult

Stichwörter der Autor:innen

Ki67MART1Melan‐Adual multiplex immunohistochemistrymelanomanevus

Substanzen

Ki-67 AntigenMART-1 AntigenMLANA protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

ORCID-Profile: Peter N Kundert, Elsayed H Ibrahim, Victor G Prieto, Phyu P Aung

Zitieren

APA

Kundert, P. N., Ibrahim, E. H., Prieto, V. G., & Aung, P. P. (2026). Enhanced Melan‐A Red Chromogen Labeling in Melanoma Compared to Nevus Cells: A Diagnostic Aid in Dual Multiplex Immunohistochemistry With Ki67. Journal of Cutaneous Pathology, 53(12), 1180-1185. https://doi.org/10.1111/cup.70170

Vancouver

Kundert PN, Ibrahim EH, Prieto VG, Aung PP. Enhanced Melan‐A Red Chromogen Labeling in Melanoma Compared to Nevus Cells: A Diagnostic Aid in Dual Multiplex Immunohistochemistry With Ki67. Journal of Cutaneous Pathology. 2026;53(12):1180-1185. doi:10.1111/cup.70170

BibTeX
@article{Kundert2026,
  author = {Kundert, Peter N and Ibrahim, Elsayed H and Prieto, Victor G and Aung, Phyu P},
  title = {Enhanced Melan‐A Red Chromogen Labeling in Melanoma Compared to Nevus Cells: A Diagnostic Aid in Dual Multiplex Immunohistochemistry With Ki67},
  journal = {Journal of Cutaneous Pathology},
  year = {2026},
  volume = {53},
  number = {12},
  pages = {1180--1185},
  doi = {10.1111/cup.70170}
}
Kostenlos starten →